Naser Ahmad Joudeh - Mar 3, 2021 Form 4 Insider Report for Medicine Man Technologies, Inc. (SHWZ)

Role
Filer
Signature
Naser Ahmad Joudeh
Stock symbol
SHWZ
Transactions as of
Mar 3, 2021
Transactions value $
$1,959,000
Form type
4
Date filed
7/12/2021, 02:57 PM
Previous filing
Jul 12, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SHWZ Series A Cumulative Convertible Preferred Stock Award $547K +547 +22.39% $1,000.00* 2.99K Mar 2, 2021 Common stock 456K $1.20 Direct F1, F2, F3
transaction SHWZ Series A Cumulative Convertible Preferred Stock Award $865K +865 +28.93% $1,000.00* 3.86K Mar 2, 2021 Common stock 721K $1.20 Spouse F1, F2, F3
transaction SHWZ Series A Cumulative Convertible Preferred Stock Award $547K +547 +7.67% $1,000.00* 7.68K Mar 2, 2021 Common stock 3.19M $1.20 Spouse F1, F2, F3
transaction SHWZ Warrant (Right to Buy) Award +103K 103K Mar 2, 2021 Common stock 103K $1.20 Direct F4
transaction SHWZ Warrant (Right to Buy) Award +162K +158.02% 265K Mar 2, 2021 Common stock 162K $1.20 Spouse F4
transaction SHWZ Warrant (Right to Buy) Award +718K +271.31% 982K Mar 2, 2021 Common stock 718K $1.20 Spouse F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to adjustment, as described in the Certificate of Designation.
F2 The shares of Series A Cumulative Convertible Preferred Stock (the "Series A Preferred Shares") are convertible into shares of the common stock (the "Common Shares") of Medicine Man Technologies, Inc. (the "Company") upon the events specified in the Company's Certificate of Designation of Series A Cumulative Convertible Preferred Stock (the "Certificate of Designation"). The Preferred stock is perpetual and therefore has no expiration date.
F3 Represents the number of Common Shares issuable upon conversion of the Series A Preferred Shares on the date of the reported transaction. Each Series A Preferred Share is convertible into that number of Common Shares equal to the preference amount (initially $1,000) plus any accrued dividends with respect to such share, divided by the conversion price (initially $1.20), subject to adjustment as set forth in the Certificate of Designation. The Series A Preferred Shares earn a cumulative dividend of 8% per annum.
F4 The reporting person received the warrants under Asset Purchase Agreements entered into by entities partly-owned by the reporting person upon the sale of assets by such entities to the issuer on the following date: March 3, 2021.